GBLT Corp. receives expanded order from a European retailer

TORONTO and DUEREN — GBLT Corp. announces that it has received an additional order from a European retailer, and one of the top 5 largest retailers globally, for EUR606,000 (CDN $870,000), on top of the existing EUR9.9m (CDN $13.8m) anticipated revenue from this one client in calendar year 2022. The order marks continued sales of GBLT’s proprietary brand of Dr. Senst branded healthcare line.

The Company anticipates this order to be delivered and recognized in Q3 2022.

“More than ever, our opportunity to expand with existing retailer clients is driving phenomenal growth in our top line revenue and ultimately our profitability going forward,” said Dr. Thilo Senst, CEO and Founder of GBLT Corp. “Our business is rapidly shifting towards higher margin sales from an even wider scope of solutions branded under the Dr. Senst line. When we initially penetrated these clients with the sale of masks in early 2020, we could not have envisioned how massively this brand of products would expand, and we are now delivering a variety of products, at the direct request of our growing client base, with many more products planned over the course of 2022.”